Home » ENDOLOGIX RECEIVES FDA APPROVAL TO MARKET VISIFLEX DELIVERY SYSTEM
ENDOLOGIX RECEIVES FDA APPROVAL TO MARKET VISIFLEX DELIVERY SYSTEM
May 24, 2006
Endologix Inc. said it received U.S. Food and Drug Administration approval to begin marketing its next-generation Visiflex Delivery System for use with the Powerlink System to treat abdominal aortic aneurysm.
Trading Markets Live
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct